Factors Associated with Total Laryngectomy Utilization in Patients with cT4a Laryngeal Cancer
Author:
Ritter Alex R.1, Yildiz Vedat O.2, Koirala Nischal1, Baliga Sujith1, Gogineni Emile1ORCID, Konieczkowski David J.1, Grecula John1, Blakaj Dukagjin M.1, Jhawar Sachin R.1ORCID, VanKoevering Kyle K.3, Mitchell Darrion1ORCID
Affiliation:
1. Department of Radiation Oncology, The Ohio State University Wexner Medical Center, 410 W 10th Ave., Columbus, OH 43210, USA 2. Department of Biomedical Informatics, Center for Biostatistics, Ohio State University, 1800 Cannon Dr., Columbus, OH 43210, USA 3. Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, 410 W 10th Ave., Columbus, OH 43210, USA
Abstract
Background: Despite recommendations for upfront total laryngectomy (TL), many patients with cT4a laryngeal cancer (LC) instead undergo definitive chemoradiation, which is associated with inferior survival. Sociodemographic and oncologic characteristics associated with TL utilization in this population are understudied. Methods: This retrospective cohort study utilized hospital registry data from the National Cancer Database to analyze patients diagnosed with cT4a LC from 2004 to 2017. Patients were stratified by receipt of TL, and patient and facility characteristics were compared between the two groups. Logistic regression analyses and Cox proportional hazards methodology were performed to determine variables associated with receipt of TL and with overall survival (OS), respectively. OS was estimated using the Kaplan–Meier method and compared between treatment groups using log-rank testing. TL usage over time was assessed. Results: There were 11,149 patients identified. TL utilization increased from 36% in 2004 to 55% in 2017. Treatment at an academic/research program (OR 3.06) or integrated network cancer program (OR 1.50), male sex (OR 1.19), and Medicaid insurance (OR 1.31) were associated with increased likelihood of undergoing TL on multivariate analysis (MVA), whereas age > 61 (OR 0.81), Charlson–Deyo comorbidity score ≥ 3 (OR 0.74), and clinically positive regional nodes (OR 0.78 [cN1], OR 0.67 [cN2], OR 0.21 [cN3]) were associated with decreased likelihood. Those undergoing TL with post-operative radiotherapy (+/− chemotherapy) had better survival than those receiving chemoradiation (median OS 121 vs. 97 months; p = 0.003), and TL + PORT was associated with lower risk of death compared to chemoradiation on MVA (HR 0.72; p = 0.024). Conclusions: Usage of TL for cT4a LC is increasing over time but remains below 60%. Patients seeking care at academic/research centers are significantly more likely to undergo TL, highlighting the importance of decreasing barriers to accessing these centers. Increased focus should be placed on understanding and addressing the additional patient-, physician-, and system-level factors that lead to decreased utilization of surgery.
Subject
Cancer Research,Oncology
Reference52 articles.
1. Cancer statistics;Siegel;CA Cancer J. Clin.,2022 2. Park, J.-O., Nam, I.-C., Kim, C.-S., Park, S.-J., Lee, D.-H., Kim, H.-B., Han, K.-D., and Joo, Y.-H. (2022). Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People. Cancers, 14. 3. Occupational exposure to chlorinated solvents and risk of head and neck cancer in men: A population-based case-control study in France;Barul;Environ. Health,2017 4. Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf, G.T., Fisher, S.G., Hong, W.K., Hillman, R., Spaulding, M., Laramore, G.E., Endicott, J.W., McClatchey, K., and Henderson, W.G. (1991). Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer. N. Engl. J. Med., 324, 1685–1690. 5. Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients with Locally Advanced Larynx Cancer;Forastiere;J. Clin. Oncol.,2013
|
|